Apoptosis in critical illness

International Anesthesiology Clinics

Volumn 41, Issue 1, 2003, Pages 65-77

  Lydon, Avine ^a   Martyn, J A Jeevendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; EPIDERMAL GROWTH FACTOR; GENTAMICIN; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN P53; SCATTER FACTOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; CELL DEATH; CONGESTIVE HEART FAILURE; CRITICAL ILLNESS; HODGKIN DISEASE; HUMAN; IMMUNE SYSTEM; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIVER FAILURE; MYOPATHY; PRIORITY JOURNAL; REVIEW; SEPSIS;

EID: 0037412771     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200341010-00006     Document Type: Review

References (29)

1. Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis. Crit Care Med 1995;23:276-393
2. Papathanassoglou E, Moynihan J, Ackerman M. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Crit Care Med 2000;28:537-549
3. Hengartner M. The biochemistry of apoptosis. Nature 2000;407:770-776
4. Yuan J. Transducing signals of life and death. Curr Opin Cell Biol 1997;9:35-49
5. Ueda N, Kaushal G, Shah S. Apoptotic mechanisms in acute renal failure. Am J Med 2000;108:403-415
6. Burns AT, Davies DR, McLaren AJ, et al. Apoptosis in ischemia/reperfusion injury of human allografts. Transplantation 1998;66:872-876
7. Kiyokawa N, Taguchi T, Mori T, et al. Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli shiga toxins 1 and 2. J Infect Dis 1998;178: 178-184
8. Hirschberg R, Ding H. Growth factors and acute renal failure. Sem Nephrol 1998;18: 191-207
9. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141
10. Haendeler J, Messmer U, Brüne B, et al. Endotoxic shock leads to apoptosis in vivo and reduces Bcl-2. Shock 1996;6:405-409
11. Abraham E. What role does neutrophil apoptosis play in acute respiratory distress syndrome? Crit Care Med 2000;28:253-254
12. Matute-Bello G, Conrad Liles W, Radella F, et al. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;156:1969-1977
13. Hussain N, Wu F, Zhu L, et al. Neutrophil apoptosis during the development and resolution of oleic acid-induced acute lung injury in the rat. Am J Respir Cell Mol Biol 1998;19:867-874
14. Hashimoto S, Kobayashi A, Kooguchi K, et al. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000;161:237-243
15. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996;24:1408-1416
16. Yasuhara S, Perez M, Kanakubo E, et al. Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab 2000; 279:E1114-E1121
17. Allen DL, Linderman JK, Roy RR, et al. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol Cell Physiol 1997;273:C579-C587
18. Ikezu T, Okamoto T, Yonezawa K, et al. Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J Biol Chem 1997;272: 25289-25295
19. Hirose M, Kaneki M, Sugita H, et al. Immobilization depresses insulin signalling in skeletal muscle. Am J Physiol Endocrinol Metab 2000;279:E1235-E1241
20. Nicholson D. From bench to clinic with apoptosis-based therapeutic agents. Nature 2000;407:810-816
21. Schlagbauer-Wadl H, Klosner G, Heere-Ress E, et al. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice. J Invest Dermatol 2000;114:725-730
22. Waters JS, Webb A, Cunningham D, et al. Phase I clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J Clin Oncol 2000;18:1812-1823
23. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med 1999;54:225-234
24. Mignon A, Rouquet N, Fabre M, et al. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med 1999;159:1308-1315
25. Mocanu MM, Baxter GF, Yellon DM. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 2000;130:197-200
26. Hotchkiss RS, Tinsley kW, Swanson PE, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999;96:14541-14546
27. Kawasaki M, Kuwano K, Hagimoto N, et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury, in mice by a caspase inhibitor. Am J Pathol 2000;157:597-603
28. Suwabe A, Otake K, Yakuwa N, et al. Artificial surfactant (Surfactant TA) modulates adherence and superoxide production of neutrophils. Am J Respir Crit Care Med 1998;158:1890-1899
29. Debroy MA, Wolf SE, Zhang XZ, et al. Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J Trauma 1999;47:904-910